Jensen Flemming Steen

Jensen Flemming Steen is listed in filings as See Remarks at Ascendis Pharma A/S. This profile follows SEC Form 4 activity through May 12, 2026, including sale activity. Recent filings connect the profile to Ascendis Pharma A/S (ASND). The current snapshot covers public activity from May 12, 2026. Reported amounts are shown as $4.6M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.